Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study

@inproceedings{Bitter2010PatientsPF,
  title={Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study},
  author={Istv{\'a}n Bitter and Tam{\'a}s Treuer and Nesrin Dilbaz and Igor Oyffe and Eda M Ciorabai and S Gonz{\'a}lez and Sandra In{\^e}s Ruschel and Jolanta Salburg and Yulia Dyachkova},
  booktitle={The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry},
  year={2010}
}
OBJECTIVES The aim of this study was to compare patients' preference for olanzapine orodispersible tablet (ODT) with oral conventional tablet (OCT). METHODS A 12-week randomized, crossover, multinational, open-label study was conducted to estimate the proportion of patients preferring ODT or OCT. Outpatients with stable schizophrenia on OCT monotherapy were randomly assigned 1:1 to ODT or OCT. Compliance and drug attitude were measured using the Drug Attitude Inventory (DAI-10) and Medication… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Orodispersible drug formulations for children and elderly.

  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2015
VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Naturalistic use of the orally disintegrating tablet formulation of olanzapine in acute schizophrenic patients: An observational prospective study

R Dardennes, F Chartier, N Heurtebize, V Olivier, E. Perrin
  • Int J Neuropsychopharmacol 7
  • 2004
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL